EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Levofloxacin induces differential effects in the transcriptome between the gut, peripheral and axial joints in the Spondyloarthritis DBA/1 mice: Improvement of intestinal dysbiosis and the overall inflammatory process

Susana Aideé González-Chávez, Joan S Salas-Leiva, Dayana E Salas-Leiva, Salma Marcela López-Loeza, Jasanai Sausameda-García, Erasmo Orrantia-Borunda, Rubén Burgos-Vargas, Maria Fernanda Alvarado-Jáquez, Mayra Torres-Quintana, Rubén Cuevas-Martínez, Eduardo Chaparro-Barrera iD, Carlos Marín-Terrazas und 4 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0281265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Susana Aideé González-Chávez und 15 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina y Ciencias Biomédicas, Laboratorio PABIOM, Universidad Autónoma de Chihuahua, Chihuahua, México. Hauptthemen laut MEDLINE: Levofloxacin, Spondylarthritis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To analyze the effect of levofloxacin-induced intestinal microbiota modifications on intestinal, joint, and systemic inflammation in the DBA/1 mice with spontaneous arthritis. The study included two groups of mice, one of which received levofloxacin. The composition and structure of the microbiota were determined in the mice’s stool using 16S rRNA sequencing; the differential taxa and metabolic pathway between mice treated with levofloxacin and control mice were also defied. The effect of levofloxacin was evaluated in the intestines, hind paws, and spines of mice through DNA microarray transcriptome and histopathological analyses; systemic inflammation was measured by flow cytometry. Levofloxacin decreased the pro-inflammatory bacteria, including Prevotellaceae, Odoribacter, and Blautia, and increased the anti-inflammatory Muribaculaceae in mice’s stool. Histological analysis confirmed the intestinal inflammation in control mice, while in levofloxacin-treated mice, inflammation was reduced; in the hind paws and spines, levofloxacin also decreased the inflammation. Microarray showed the downregulation of genes and signaling pathways relevant in spondyloarthritis, including several cytokines and chemokines. Levofloxacin-treated mice showed differential transcriptomic profiles between peripheral and axial joints and intestines. Levofloxacin decreased the expression of TNF-α, IL-23a, and JAK3 in the three tissues, but IL-17 behaved differently in the intestine and the joints. Serum TNF-α was also reduced in levofloxacin-treated mice. Our results suggest that the microbiota modification aimed at reducing pro-inflammatory and increasing anti-inflammatory bacteria could potentially be a coadjuvant in treating inflammatory arthropathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevofloxacinSpondylarthritisMiceAnimalsTranscriptomeTumor Necrosis Factor-alphaDysbiosisRNA, Ribosomal, 16SMice, Inbred DBAInflammationMice, Inbred C57BL

Substanzen

LevofloxacinTumor Necrosis Factor-alphaRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Facultad de Medicina y Ciencias Biomédicas, Laboratorio PABIOM, Universidad Autónoma de Chihuahua, Chihuahua, México.
  • Departamento de Medio Ambiente y Energía, CONACyT-Centro de Investigación en Materiales Avanzados, Chihuahua, México.
  • Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
  • Department of Biochemistry and Molecular Biology, Institute for Comparative Genomics (ICG), Dalhousie University, Halifax, NS, Canada.
  • Department of Rheumatology, Hospital General de México, "Dr. Eduardo Liceaga", Ciudad de México, México.
  • Translational Research Laboratory and National Laboratory of Flow Cytometry, Autonomous University of Chihuahua, Circuito Universitario, Campus II, Chihuahua, Mexico.

ORCID-Profile: Eduardo Chaparro-Barrera, Gerardo Pável Espino-Solís, José Pablo Romero-López, César Pacheco-Tena

Zitieren

APA

González-Chávez, S. A., Salas-Leiva, J. S., Salas-Leiva, D. E., López-Loeza, S. M., Sausameda-García, J., Orrantia-Borunda, E., Burgos-Vargas, R., Alvarado-Jáquez, M. F., Torres-Quintana, M., Cuevas-Martínez, R., Chaparro-Barrera, E., Marín-Terrazas, C., Espino-Solís, G. P., Romero-López, J. P., Bernal-Alferes, B. J., & Pacheco-Tena, C. (2023). Levofloxacin induces differential effects in the transcriptome between the gut, peripheral and axial joints in the Spondyloarthritis DBA/1 mice: Improvement of intestinal dysbiosis and the overall inflammatory process. PLOS ONE. https://doi.org/10.1371/journal.pone.0281265

Vancouver

González-Chávez SA, Salas-Leiva JS, Salas-Leiva DE, López-Loeza SM, Sausameda-García J, Orrantia-Borunda E, et al. Levofloxacin induces differential effects in the transcriptome between the gut, peripheral and axial joints in the Spondyloarthritis DBA/1 mice: Improvement of intestinal dysbiosis and the overall inflammatory process. PLOS ONE. 2023. doi:10.1371/journal.pone.0281265

BibTeX
@article{GonzlezChvez2023,
  author = {González-Chávez, Susana Aideé and Salas-Leiva, Joan S and Salas-Leiva, Dayana E and López-Loeza, Salma Marcela and Sausameda-García, Jasanai and Orrantia-Borunda, Erasmo and Burgos-Vargas, Rubén and Alvarado-Jáquez, Maria Fernanda and Torres-Quintana, Mayra and Cuevas-Martínez, Rubén and Chaparro-Barrera, Eduardo and Marín-Terrazas, Carlos and Espino-Solís, Gerardo Pável and Romero-López, José Pablo and Bernal-Alferes, Brian de Jesús and Pacheco-Tena, César},
  title = {Levofloxacin induces differential effects in the transcriptome between the gut, peripheral and axial joints in the Spondyloarthritis DBA/1 mice: Improvement of intestinal dysbiosis and the overall inflammatory process},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0281265}
}
Kostenlos starten →